CNR1 and cervical cancer: Moreover, Ramer and Hinz (2008) used human cervical cancer cells (HeLa) to assess invasiveness following treatment with an endogenous cannabinoid (anandamide) analog R( +)-methanandamide (MA) and THC with or without CB1 and CB2 receptor antagonists.